Détail d'une personne de l'annuaire - fr | Cancéropôle Est, la recherche innovante dans la lutte contre le cancer

Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort.

Thomas QD, Quantin X, Lemercier P, Chouaid C, Schneider S, Filleron T, Remon-Masip J, Perol M, Debieuvre D, Audigier-Valette C, Justeau G, Loeb A, Hiret S, Clement-Duchene C, Dansin E, Stancu A, Pichon E, Bosquet L, Girard N, Du Rusquec P

ESMO Open. 2024 06 3;9(6):103473

Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.

Baldacci S, Besse B, Avrillon V, Mennecier B, Mazieres J, Dubray-Longeras P, Cortot AB, Descourt R, Doubre H, Quantin X, Duruisseaux M, Monnet I, Moro-Sibilot D, Cadranel J, Clément-Duchêne C, Cousin S, Ricordel C, Merle P, Otto J, Schneider S, Langlais A, Morin F, Westeel V, Girard N

Eur J Cancer. 2022 Mar 9;166:51-59

Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network.

Petat A, Dansin E, Calcagno F, Greillier L, Pichon E, Kerjouan M, Clement-Duchene C, Mennecier B, Westeel V, Thillays F, Quantin X, Oulkhouir Y, Thiberville L, Ricordel C, Thomas De Montpreville V, Chalabreysse L, Hofman V, Molina T, Fournel P, Bigay Game L, Besse B, Girard N

Eur J Cancer. 2021 Dec 26;162:118-127

A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.

Chouaid C, Filleron T, Debieuvre D, Pérol M, Girard N, Dansin E, Lena H, Gervais R, Cousin S, Otto J, Schott R, Planchard D, Madroszyk A, Kaderbhai C, Dubray-Longeras P, Hiret S, Pichon E, Clément-Duchêne C, Chenuc G, Simon G, Bosquet L, QUantin X

Target Oncol. 2021 Oct 18;:

Central nervous system metastases in thymic epithelial tumors: a brief report of real-world insight from RYTHMIC.

Benitez JC, Boucher ME, Dansin E, Kerjouan M, Bigay-Game L, Pichon E, Thillays F, Falcoz PE, Lyubimova S, Oulkhouir Y, Calcagno F, Thiberville L, Clément-Duchêne C, Westeel V, Missy P, Thomas P, Maury JM, Molina T, Girard N, Besse B

J Thorac Oncol. 2021 Aug 26;:

RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection.

Basse C, Botticella A, Molina TJ, Falcoz PE, Oulkhouir Y, Kerjouan M, Pichon E, Westeel V, Thiberville L, Quantin X, Clément-Duchêne C, Khalifa J, Tinier FL, Ginoux M, Thillays F, Mordant P, Besse B, Thomas PA, Péchoux CL, Girard N

Clin Lung Cancer. 2021 Feb 4;:

Prospective multi-center validation of the detection of ALK rearrangements of circulating tumor cells for non-invasive longitudinal management of patients with advanced non-small cell lung cancer.

Ilie M, MaziÈres J, Chamorey E, Heeke S, Benzaquen J, Thamphya B, Boutros J, Tiotiu A, Fayada J, Cadranel J, Poudenx M, Moro-Sibilot D, Barlesi F, Thariat J, Clement-Duchene C, Tomasini P, Hofman V, Marquette CH, Hofman P,

J Thorac Oncol. 2021 Feb 3;:

Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors.

Giordan Q, Salleron J, Vallance C, Moriana C, Clement-Duchene C

Front Immunol. 2021 ;12:716317

Safety and feasibility of thoracic malignancy surgery during the COVID-19 pandemic.

Seitlinger J, Wollbrett C, Mazzella A, Schmid S, Guerrera F, Nkomo DB, Hassan M, Brindel A, Ruuth-Praz J, Schmitt P, Clément-Duchêne C, Douiri N, Reeb J, Prisciandaro E, Siat J, Spaggiari L, Ruffini E, Filosso P, Ferri L, Santelmo N, Spicer J, Renaud S

Ann Thorac Surg. 2020 Dec 14;:

ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer.

Clément-Duchêne C

Ann. Surg. Oncol.. 2018 Sep 22;:

Systemic therapy in advanced thymic epithelial tumors: Insights from the RYTHMIC prospective cohort.

Merveilleux du Vignaux C, Dansin E, Mhanna L, Greillier L, Pichon E, Kerjouan M, Clement-Duchene C, Mennecier B, Westeel V, Robert M, Quantin X, Zalcman G, Thiberville L, Lena H, Molina T, Calcagno F, Fournel P, Mazieres J, Besse B, Girard N

J Thorac Oncol. 2018 Aug 20;:

Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital.

Clément-Duchêne C, Luc A, Casse JM, Vignaud JM, Lacomme S, Anne V, Siat J, Ménard O, Martinet Y

Ann. Surg. Oncol.. 2018 May;25(5):1262-1268

Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.

Renaud S, Seitlinger J, Guerrera F, Reeb J, Beau-Faller M, Voegeli AC, Siat J, Clément-Duchêne C, Tiotiu A, Santelmo N, Costardi L, Ruffini E, Falcoz PE, Vignaud JM, Massard G

Ann. Surg. Oncol.. 2018 Apr;25(4):1069-1078

A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy.

Gubens MA, Chuang JC, Akerley W, Langer CJ, Clément-Duchêne C, San Pedro-Salcedo M, Colevas AD, Dragnev K, Socinski MA, Wakelee HA

J Thorac Dis. 2018 Jan;10(1):219-227

[Prophylactic radiotherapy in a single fraction of 10Gy at intervention pleural site in patient with malignant pleural mesothelioma: A retrospective monocentric cohort study].

Carette H, Faivre JC, Salleron J, Baumann AS, Uwer L, Clément-Duchêne C, Vignaud JM, Petit I, Siat J, Tiotiu A, Beckendorf V

Cancer Radiother. 2017 Dec;21(8):774-783

Multidisciplinary tumor board decision-making for postoperative radiotherapy in thymic epithelial tumors: Insights from the RYTHMIC prospective cohort.

Basse C, Thureau S, Bota S, Dansin E, Thomas PA, Pichon E, Lena H, Massabeau C, Clement-Duchene C, Massard G, Westeel V, Quantin X, Oulkhouir Y, Danhier S, Lerouge D, Tanguy R, Thillays F, Le Pechoux C, Dubray B, Thiberville L, Besse B, Girard N

J Thorac Oncol. 2017 Jul;:

[Complementary and alternative medicine use by lung cancer patients].

Rossanaly Vasram R, Zysman M, Ribeiro Baptista B, Ederle C, Nguyen-Thi PL, Clement-Duchene C, Martinet Y

Rev Pneumol Clin. 2017 Jul;:

[Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?]

Royer P, Salleron J, Vogin G, Taillandier L, Clément-Duchêne C, Klein O, Faivre JC, Peiffert D, Bernier V

Cancer Radiother. 2017 Jul;:

[Malignant rhabdoid tumor of the lung].

Zysman M, Clement-Duchene C, Bastien C, Vaillant P, Martinet Y

Rev Mal Respir. 2016 Nov;33(9):808-811

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.

Fiteni F, Vernerey D, Bonnetain F, Vaylet F, Sennélart H, Trédaniel J, Moro-Sibilot D, Herman D, Laizé H, Masson P, Derollez M, Clément-Duchêne C, Milleron B, Morin F, Zalcman G, Quoix E, Westeel V

Eur. J. Cancer. 2016 Jan;52:120-8

[Management of chemotherapy-induced anemia in lung cancer].

Tiotiu A, Clément-Duchêne C, Martinet Y

Rev Mal Respir. 2015 Oct;32(8):809-21

Bevacizumab in Patients with Non-Squamous Non-Small-Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): a Non-Randomised, Phase II Study.

Besse B, Le Moulec S, Maazieres J, Senellart H, Barlesi F, Chouaid C, Dansin E, Berard H, Falchero L, Gervais R, Robinet G, Ruppert AM, Schott R, Lena H, Clement-Duchene C, Quantin X, Souquet PJ, Tredaniel J, Moro-Sibilot D, Perol M, Madroszyk AC, Soria JC

Clin Cancer Res. 2015 Jan 22. pii: clincanres.2082.2014.

Is there a relationship between the presence of lung mucosa preinvasive lesions and lung cancer incidence? Influence of tobacco consumption.

Clement-Duchene C, Alla F, Gauchotte G, Marie B, Carnin C, Menard O, Vignaud JM, Martinet Y

Lung Cancer. 2014 May;84(2):134-8

[Evaluation of requests for a second medical opinion by patients with lung cancer].

Zysman M, Clement-Duchene C, Nguyen-Thi PL, Carnin C, Martinet Y

Rev Mal Respir. 2014 May;31(5):412-20

CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.

Elakoum R, Gauchotte G, Oussalah A, Wissler MP, Clement-Duchene C, Vignaud JM, Gueant JL, Namour F

Biochimie. 2014 Feb;97:210-8

Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival.

Lemonnier I, Guillemin F, Arveux P, Clement-Duchene C, Velten M, Woronoff-Lemsi MC, Jolly D, Baumann C

Health Qual Life Outcomes. 2014 May 15;12:73

A combination of smears and cell block preparations provides high diagnostic accuracy for endobronchial ultrasound-guided transbronchial needle aspiration.

Gauchotte G, Vignaud JM, Menard O, Wissler MP, Martinet Y, Siat J, Paris C, Clement-Duchene C

Virchows Arch. 2012 Nov;461(5):505-12

Occupational risk factors have to be considered in the definition of high-risk lung cancer populations.

Wild P, Gonzalez M, Bourgkard E, Courouble N, Clement-Duchene C, Martinet Y, Fevotte J, Paris C

Br J Cancer. 2012 Mar 27;106(7):1346-52

[Anti-angiogenic agents in the treatment of lung cancer: indications and toxicities].

Clement-Duchene C, Godbert B, Martinet Y

Rev Mal Respir. 2012 Feb;29(2):161-77

Smoking, occupational risk factors, and bronchial tumor location: a possible impact for lung cancer computed tomography scan screening.

Gonzalez M, Vignaud JM, Clement-Duchene C, Luc A, Wild P, Bertrand O, Thiberville L, Martinet Y, Benichou J, Paris C

J Thorac Oncol. 2012 Jan;7(1):128-36

Dr CLEMENT-DUCHENE Christelle

Fiche personne

coordonnées

Territoire

Statut

affiliation

équipes/plateformes

Recherche

Publications